Details
Stereochemistry | RACEMIC |
Molecular Formula | C13H20N2O3S |
Molecular Weight | 284.374 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)\C=C1/SC(N2CCCCC2)C(=O)N1C
InChI
InChIKey=ZCKKHYXUQFTBIK-KTKRTIGZSA-N
InChI=1S/C13H20N2O3S/c1-3-18-11(16)9-10-14(2)12(17)13(19-10)15-7-5-4-6-8-15/h9,13H,3-8H2,1-2H3/b10-9-
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | ELKAPIN Approved UseUnknown |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/578770 |
Primary | ELKAPIN Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[LOCALIZATION OF THE SITE OF ACTION OF THE DIURETIC ETOZOLIN IN THE MEPHRON OF THE DOG AND REPORT OF A MATHEMATICAL EVALUATION METHOD OF STOP-FLOW EXPERIMENTS]. | 1964 Nov 25 |
|
[Structure-activity relationships of etozolin, a novel diuretic (author's transl)]. | 1977 |
|
[On the pharmacology of Etozolin (author's transl)]. | 1977 |
|
[Toxicological studies on Etozolin (author's transl)]. | 1977 |
|
[Studies on the diuretic effects of etozolin (Elkapin) in heart failure - a comparison with the loop diuretic agent furosemide (author's transl)]. | 1979 Apr 20 |
|
Pharmacodynamics and kinetics of etozolin/ozolinone in hypertensive patients with normal and impaired kidney function. | 1984 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1417365
Isolated rings of guinea-pig aorta were treated with etozolin (10 uM-1 mM). At those concentrations, the drug inhibited noradrenaline- and histamine-induced contractions. At very low concentrations (1 nM-0.1 uM), it inhibited also serotonin-induced contractions.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C49184
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
||
|
WHO-ATC |
C03CX01
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
||
|
WHO-VATC |
QC03CX01
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
||
|
NCI_THESAURUS |
C270
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C65600
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
200-794-0
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
SUB07344MIG
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
310039
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
DTXSID40874489
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
5743585
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
95406-04-5
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
SUPERSEDED | |||
|
CHEMBL330829
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
266-691-8
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
ALTERNATIVE | |||
|
1699
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
UEO8UW9V1Z
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
100000082134
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
DB08982
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
73-09-6
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
Etozolin
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
m5204
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | Merck Index | ||
|
C015208
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
1114
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
PRIMARY | |||
|
67432-21-7
Created by
admin on Fri Dec 15 16:25:33 GMT 2023 , Edited by admin on Fri Dec 15 16:25:33 GMT 2023
|
ALTERNATIVE |
ACTIVE MOIETY
METABOLITE ACTIVE (PARENT)